Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Return on Assets (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Return on Assets data on record, last reported at 1.04% in Q3 2025.

  • For Q3 2025, Return on Assets rose 73.0% year-over-year to 1.04%; the TTM value through Sep 2025 reached 1.04%, up 73.0%, while the annual FY2024 figure was 1.61%, 179.0% up from the prior year.
  • Return on Assets reached 1.04% in Q3 2025 per COEP's latest filing, down from 0.98% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.34% in Q4 2021 and bottomed at 4.6% in Q4 2023.
  • Average Return on Assets over 5 years is 2.12%, with a median of 1.61% recorded in 2022.
  • Peak YoY movement for Return on Assets: tumbled -300bps in 2023, then skyrocketed 338bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.34% in 2021, then tumbled by -440bps to 1.82% in 2022, then plummeted by -152bps to 4.6% in 2023, then skyrocketed by 74bps to 1.22% in 2024, then rose by 15bps to 1.04% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 1.04% in Q3 2025, 0.98% in Q2 2025, and 1.01% in Q1 2025.